Non-Invasive Kidney Stone Therapy Program
Urology practices and ASCs adding office-based stone treatment without anesthesia.
$4,997 program advisory · device and consumables quoted directly by the manufacturerRequest a proposal
The device
SonoMotion — non-invasive stone treatment system. Intended use per the manufacturer’s current FDA clearance or approval: non-invasive fragmentation of kidney stones. Indications, contraindications and training requirements are set by SonoMotion; ClearLine confirms the current labeling with the manufacturer during the assessment.
What the advisory includes
Clinical and financial case for a non-invasive stone treatment system program at your site
Manufacturer engagement, quote and contract review with SonoMotion or its authorized distributor
Credentialing, training, workflow and reimbursement plan
Go-live checklist and 90-day utilization review
How it works
1
Intake call: volumes, payer mix, current pathway
2
Program assessment and business case
3
Procurement support through contract
4
Launch plan and 90-day review
Who it’s for
Urology practices and ASCs adding office-based stone treatment without anesthesia.
Non-Invasive Kidney Stone Therapy Program — $4,997
Request a proposalClearLine Healthcare Consulting is an independent advisor and is not affiliated with or endorsed by SonoMotion. Equipment is purchased from the manufacturer or its authorized distributor under their terms.